Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$3.44 - $6.87 $165,464 - $330,447
48,100 New
48,100 $330,000
Q2 2021

Aug 11, 2021

BUY
$10.15 - $17.25 $104,545 - $177,675
10,300 Added 31.89%
42,600 $682,000
Q1 2021

May 17, 2021

BUY
$10.6 - $21.27 $145,220 - $291,399
13,700 Added 73.66%
32,300 $400,000
Q4 2020

Feb 16, 2021

BUY
$4.95 - $11.45 $92,070 - $212,970
18,600 New
18,600 $207,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $49.7M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.